1. Home
  2. PHLT vs ARTV Comparison

PHLT vs ARTV Comparison

Compare PHLT & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHLT
  • ARTV
  • Stock Information
  • Founded
  • PHLT 1976
  • ARTV 2019
  • Country
  • PHLT United States
  • ARTV United States
  • Employees
  • PHLT N/A
  • ARTV N/A
  • Industry
  • PHLT Other Consumer Services
  • ARTV
  • Sector
  • PHLT Consumer Discretionary
  • ARTV
  • Exchange
  • PHLT Nasdaq
  • ARTV NYSE
  • Market Cap
  • PHLT 187.1M
  • ARTV 186.1M
  • IPO Year
  • PHLT N/A
  • ARTV 2024
  • Fundamental
  • Price
  • PHLT $2.37
  • ARTV $3.77
  • Analyst Decision
  • PHLT
  • ARTV Strong Buy
  • Analyst Count
  • PHLT 0
  • ARTV 6
  • Target Price
  • PHLT N/A
  • ARTV $21.00
  • AVG Volume (30 Days)
  • PHLT 131.9K
  • ARTV 83.1K
  • Earning Date
  • PHLT 03-11-2025
  • ARTV 03-04-2025
  • Dividend Yield
  • PHLT N/A
  • ARTV N/A
  • EPS Growth
  • PHLT N/A
  • ARTV N/A
  • EPS
  • PHLT N/A
  • ARTV N/A
  • Revenue
  • PHLT $120,782,000.00
  • ARTV $2,601,000.00
  • Revenue This Year
  • PHLT $9.72
  • ARTV N/A
  • Revenue Next Year
  • PHLT $9.90
  • ARTV N/A
  • P/E Ratio
  • PHLT N/A
  • ARTV N/A
  • Revenue Growth
  • PHLT 9.39
  • ARTV N/A
  • 52 Week Low
  • PHLT $2.26
  • ARTV $3.37
  • 52 Week High
  • PHLT $4.35
  • ARTV $17.31
  • Technical
  • Relative Strength Index (RSI)
  • PHLT N/A
  • ARTV N/A
  • Support Level
  • PHLT N/A
  • ARTV N/A
  • Resistance Level
  • PHLT N/A
  • ARTV N/A
  • Average True Range (ATR)
  • PHLT 0.00
  • ARTV 0.00
  • MACD
  • PHLT 0.00
  • ARTV 0.00
  • Stochastic Oscillator
  • PHLT 0.00
  • ARTV 0.00

About PHLT Performant Healthcare Inc. Common Stock

Performant Healthcare Inc delivers payment integrity solutions for its healthcare payer clients.

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.

Share on Social Networks: